The role of T cells in the microenvironment of Hodgkin lymphoma

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

(2015) Stephen M. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Flow cytometry CD4+CD26−CD38+ lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes

(2014) Rosa Di Gaetano et al.   ANNALS OF HEMATOLOGY

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells

(2014) J. Reichel et al.   BLOOD

The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing

(2014) Y Liu et al.   LEUKEMIA

GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma

(2013) Eliza A. Hawkes et al.   ANNALS OF HEMATOLOGY

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

(2013) P. Greaves et al.   BLOOD

Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma

(2013) Michelle Fanale et al.   BRITISH JOURNAL OF HAEMATOLOGY

Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor

(2013) K. Yaddanapudi et al.   JOURNAL OF IMMUNOLOGY

Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma

(2012) E. Tiacci et al.   BLOOD

Expression of CD137 on Hodgkin and Reed-Sternberg Cells Inhibits T-cell Activation by Eliminating CD137 Ligand Expression

(2012) W. T. Ho et al.   CANCER RESEARCH

The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment

(2011) Donatella Aldinucci et al.   LEUKEMIA & LYMPHOMA

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

(2011) Christian Steidl et al.   NATURE

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

(2010) M. R. Green et al.   BLOOD

Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma

(2009) Lara Cattaruzza et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells

(2008) Karl R.N. Baumforth et al.   AMERICAN JOURNAL OF PATHOLOGY

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

(2008) R. Yamamoto et al.   BLOOD

Proteolytic processing of chemokines: Implications in physiological and pathological conditions

(2008) M WOLF et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Chemotherapeutic Drugs may be Used to Enhance the Killing Efficacy of Human Tumor Antigen Peptide-specific CTLs

(2008) Pierpaolo Correale et al.   JOURNAL OF IMMUNOTHERAPY

The CD4+CD26− T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile

(2008) Yue Ma et al.   LABORATORY INVESTIGATION

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma

(2008) A. Diepstra et al.   TISSUE ANTIGENS

Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions

(2007) Donatella Aldinucci et al.   INTERNATIONAL JOURNAL OF CANCER

Autocrine NGFβ/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines

(2007) Christoph Renné et al.   LEUKEMIA RESEARCH